Dovitinib Lactate（b）

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Dovitinib (TKI258) Lactate is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM.

Dovitinib (TKI258) Lactate is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.

——

GPCR/G Protein

Antibacterial

c-Kit; FGFR1; FGFR3; FLT3; VEGFR3/FLT4

Cancer

——

915769-50-5

482.51

C24H27FN6O4

98%

——

CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C\4/C(=C5C(=NC4=O)C=CC=C5F)N)/N3.O

——

(-20℃)

With Ice Pack

≥ 2 years